Notice of Withdrawal of Certain Unapproved Abbreviated New Drug Applications, 35691-35698 [2012-14476]
Download as PDF
35691
Federal Register / Vol. 77, No. 115 / Thursday, June 14, 2012 / Notices
TABLE 1—LIST OF SAFETY AND EFFECTIVENESS SUMMARIES FOR APPROVED PMAS MADE AVAILABLE FROM JANUARY 1,
2012, THROUGH MARCH 31, 2012—Continued
PMA No., Docket No.
Applicant
Trade name
P060008.S046, FDA–2012–M–0210 ...
Boston Scientific Corp .........................
P030025.S086, FDA–2012–M–0209 ...
Boston Scientific Corp .........................
P110023, FDA–2012–M–0221 ............
ev3, Inc ................................................
P070004, FDA–2012–M–0250 ............
Sientra, Inc ..........................................
´
TAXUS Liberte Paclitaxel-Eluting Coronary Stent System (Monorail and
Over-The-Wire Delivery Systems).
TAXUS Express2 Paclitaxel-Eluting
Coronary Stent System (Monorail
and Over-The-Wire Delivery Systems).
Everflex Self-Expanding Peripheral
Stent System (Everflex).
SIENTRA Silicone Gel Breast Implants.
II. Electronic Access
Persons with access to the Internet
may obtain the documents at https://
www.fda.gov/MedicalDevices/
ProductsandMedicalProcedures/
DeviceApprovalsandClearances/
PMAApprovals/default.htm and https://
www.fda.gov/MedicalDevices/
ProductsandMedicalProcedures/
DeviceApprovalsandClearances/
HDEApprovals/ucm161827.htm.
Dated: June 8, 2012.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2012–14486 Filed 6–13–12; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2012–N–0001]
Update to Electronic Common
Technical Document Module 1
AGENCY:
Food and Drug Administration,
HHS.
pmangrum on DSK3VPTVN1PROD with NOTICES
ACTION:
Notice of meeting.
The Food and Drug Administration
(FDA) is announcing the following
meeting: Update to Electronic Common
Technical Document Module 1. The
topic to be discussed is final
documentation of the Electronic
Common Technical Document (eCTD)
Module 1, which is used for electronic
submission of administrative and
prescribing information by industry.
The purpose of the meeting is to provide
clarification and answer questions from
industry and software vendors regarding
the changes being made to this module.
Registration is required in advance and
participation will be limited.
DATES: Date and Time: The meeting
will be held on Tuesday, September 18,
2012, from 8 a.m. to 11:30 a.m.
VerDate Mar<15>2010
14:34 Jun 13, 2012
The meeting will be held at
the FDA White Oak Campus, 10903
New Hampshire Ave., Bldg. 31
Conference Center, Great Room 1503,
Silver Spring, MD 20993. The following
link contains public meeting attendee
information as well as frequently asked
questions and answers regarding public
meetings at White Oak: https://
www.fda.gov/AboutFDA/
WorkingatFDA/BuildingsandFacilities/
WhiteOakCampusInformation/
ucm241740.htm.
CONTACT: Julie Quinonez, Center for
Drug Evaluation and Research, Food
and Drug Administration, 10903 New
Hampshire Ave., Bldg. 22, Rm. 1135,
Silver Spring, MD 20993, 301–796–
0282, FAX: 301–796–9876, email:
Julie.Quinonez@fda.hhs.gov.
Registration: Send registration
information (including name, title, firm
name, address, telephone, and fax
number) to Julie Quinonez (see
Contact). Registrations will be accepted
in the order that they are received with
a limit of 350.
SUPPLEMENTARY INFORMATION: The eCTD
is an International Conference on
Harmonization (ICH) standard based on
specifications developed by ICH and its
member parties. The Center for Drug
Evaluation and Research (CDER) and the
Center for Biologics Evaluation and
Research (CBER) have been receiving
submissions in the eCTD format since
2003, and the eCTD has been the
standard for electronic submissions to
CDER and CBER since January 1, 2008.
In fact, the majority of new electronic
submissions are now received in eCTD
format. Since adoption of the eCTD
standard, it has become necessary to
update the administrative portion of the
eCTD Module 1 to reflect regulatory
changes; to provide clarification of
business rules for submission,
processing, and review; to refine the
characterization of promotional labeling
and advertising material; and to
facilitate automated processing of
LOCATION:
Jkt 226001
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
Approval date
February 22, 2012.
February 22, 2012.
March 7, 2012.
March 9, 2012.
submissions. In the process of
considering these changes, FDA has
previously made available for comment
versions of documents that support
making regulatory submissions in
electronic format using the (eCTD)
specifications. These draft documents
represented FDA’s major updates to
Module 1 of the eCTD based on
previous comments. FDA will make
available revised versions of these
documents in preparation for this
meeting. These documents will be
posted at: https://www.fda.gov/Drugs/
DevelopmentApprovalProcess/
FormsSubmissionRequirements/
ElectronicSubmissions/ucm253101.htm.
If you need special accommodations
due to a disability, please contact Julie
Quinonez (see Contact) at least 7 days
in advance.
Dated: June 8, 2012.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2012–14469 Filed 6–13–12; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2012–N–0517]
Notice of Withdrawal of Certain
Unapproved Abbreviated New Drug
Applications
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA or the Agency) is
announcing its intention to deem to be
withdrawn any abbreviated new drug
applications (ANDAs) that have been
determined to be incomplete and as to
which the ANDA applicant has not
communicated with FDA since July 8,
1991. Each of these applications will be
SUMMARY:
E:\FR\FM\14JNN1.SGM
14JNN1
35692
Federal Register / Vol. 77, No. 115 / Thursday, June 14, 2012 / Notices
pmangrum on DSK3VPTVN1PROD with NOTICES
deemed to have been withdrawn
voluntarily by the applicant unless the
applicant informs the Agency in writing
that it intends to actively pursue
approval of the application(s) (see
DATES).
DATES: The applicant of an ANDA
covered by this notice that intends to
actively pursue approval of its
application must submit a written
notification to FDA by August 13, 2012.
ADDRESSES: Applicants should submit
written notifications to the ANDA
archival file to the Office of Generic
Drugs, Center for Drug Evaluation and
Research, Food and Drug
Administration, Document Control
Room, MPN7, 7620 Standish Pl.,
Rockville, MD 20855. A copy of written
notifications should also be submitted
to Thomas Hinchliffe, Center for Drug
Evaluation and Research (HFD–617),
Food and Drug Administration, 7500
Standish Pl., rm. N–142, MPN2,
Rockville, MD 20855, FAX: 240–276–
8440, email: inactiveandas@fda.hhs.gov.
FOR FURTHER INFORMATION CONTACT:
Thomas Hinchliffe, Center for Drug
Evaluation and Research (HFD–617),
Food and Drug Administration, 7500
Standish Pl., rm. N–142, MPN2,
Rockville, MD 20855, 240–276–8433,
FAX: 240–276–9310, email:
inactiveandas@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
FDA has identified 364 ANDAs for
which FDA has not received any
communication from the ANDA
applicant since July 8, 1991, or earlier
(Inactive ANDAs). (See section IV of this
document for the list of Inactive
ANDAs). For purposes of this
document, the term ‘‘applicant’’
includes any successor in interest.
FDA’s regulations provide that the
Agency will consider withdrawn any
application for which the applicant has
not contacted the Agency about its
intention regarding such application
within 1 year after issuance of a
complete response letter to the
applicant (see 21 CFR 314.110(c)). The
Inactive ANDAs, however, predate, and
consequently are not subject to this
regulation. Therefore, the Inactive
ANDAs have not been deemed
withdrawn although there has been no
communication from the applicants
since July 8, 1991, or earlier.
II. Withdrawal of Inactive ANDAs
At this time, the Agency is
announcing its intention to deem all
Inactive ANDAs to have been
voluntarily withdrawn by the respective
applicants as of August 13, 2012, unless
VerDate Mar<15>2010
14:34 Jun 13, 2012
Jkt 226001
the applicant informs the Agency in
writing by the date set forth under DATES
in this document of its intent to actively
pursue approval of the application.
Therefore, in the absence of a written
notice with respect to an Inactive ANDA
by the date specified in this notice, the
ANDA will be considered to have been
withdrawn by the applicant. No further
notice of the withdrawal of Inactive
ANDAs will be provided. Withdrawal of
an unapproved application is without
prejudice to resubmission of that
application (21 CFR 314.65). Because of
the length of time that has passed since
these applications were submitted, FDA
strongly recommends that any applicant
intending to actively pursue approval
review the application carefully to
determine whether it satisfies current
ANDA requirements (21 CFR part 314).
III. Action by the Applicant
If the applicant wishes to actively
pursue approval of an Inactive ANDA
and does not wish the application to be
deemed by FDA to have been
voluntarily withdrawn, the applicant
must inform the Agency in writing
within the time specified in this
document. Written notice should be
provided to Thomas Hinchliffe and the
Office of Generic Drugs (see ADDRESSES).
FDA also asks any applicant that
agrees to consider its application to be
voluntarily withdrawn to send a written
notice to Thomas Hinchliffe and the
Office of Generic Drugs (see ADDRESSES)
to confirm that agreement. However,
applicants of Inactive ANDAs covered
by this notice who wish their
applications to be withdrawn are not
required to provide written notice to
FDA.
IV. Details About Inactive ANDAs
Information about the Inactive
ANDAs is listed in this section of the
document. To protect applicant
confidentiality, this notice lists the
application number and drug name for
each Inactive ANDA and separately lists
the name of the applicant as shown in
the information on file with FDA,
without linking identified applicants
with specific applications or drug
names. In some cases, the identified
applicants may no longer exist as
ongoing business entities. If an
identified applicant is unsure which
application(s) belong to it (if any), it
may contact Thomas Hinchliffe (see FOR
FURTHER INFORMATION CONTACT).
Alphabetical List of Abbreviated New
Drug Application Applicants
1st Texas Pharmaceuticals, Inc.,
Subsidiary of Scherer Laboratories
Inc.
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
Abraxis Pharmaceutical Products
AH Robins, Co.
Alpharma US Pharmaceuticals Division
Ambix Laboratories Division of
Organics Corp America
Ankerfarm SpA
Ankerman SpA
Antibioticos SA
Arcum Pharmaceutical Corp.
Banner Pharmacaps, Inc.
Barr Laboratories, Inc.
Baxter Healthcare Corp.
Beecham Laboratories Division of
Beecham Inc.
Beecham SA
Bel Mar Laboratories, Inc.
Biocraft Laboratories, Inc.
Biometric Testing, Inc.
Boots Laboratories, Inc., Division of
Boots Pharmaceuticals Inc.
Bristol Laboratories, Inc., Division of
Bristol Myers Co.
Bristol Myers Co. International Division
Bristol Myers Industrial Division
Bristol Myers Squibb
Camall Co., Inc.
Carlo Erba SpA
Century Pharmaceuticals, Inc.
Chemibiotic Ireland, Ltd.
Chromalloy Laboratories Division of
Chromalloy Pharmaceuticals, Inc.
Clifford Chemical Corp.
CM Bundy Co.
Comatic Laboratories, Inc.
Credo Co.
Delco Chemical Co., Inc.
Dell Laboratories, Inc.
Dermasave Laboratories, Inc.
Dista Products Co. Division of Eli Lilly
& Co.
DM Pharmaceuticals, Inc.
Dorasol Laboratories
Dunhall Pharmaceuticals, Inc.
ER Squibb and Sons Pharmaceutical
Laboratories
Ersana, Inc., Subsidiary of ER Squibb
and Sons
Everylife
Fallek Products Co., Inc.
Farmila Farmaceutica
Faton Pharmaceuticals, Inc.
Fermion Oy
Ferndale Laboratories, Inc.
Fisons Corp.
Forest Laboratories, Inc.
Forest Pharmaceuticals, Inc.
Forrest Laboratories, Inc.
G & W Co.
Glenwood Laboratories, Inc.
Global Pharmaceutical Corp.
Gruppo Lepetit SpA Subsidiary of
Merrell Dow Pharmaceuticals, Inc.
Heather Drug Co., Inc.
Herald Pharmacal, Inc.
Hoffmann La Roche, Inc.
ICI Ltd.
Ingram Pharmaceutical Co.
Inwood Laboratories, Inc., Subsidiary of
Forest Laboratories, Inc.
E:\FR\FM\14JNN1.SGM
14JNN1
Federal Register / Vol. 77, No. 115 / Thursday, June 14, 2012 / Notices
ISF
Kasar Laboratories Division of Kasar Co.
Kasco EFCO Laboratories, Inc., Division
of Byk Gulden, Inc.
KV Pharmaceutical, Co.
Lannett Co, Inc.
Lederle Laboratories Division of
American Cyanamid Co.
Leiner Health Products, Inc.
Lemmon Co. Subsidiary of Tag
Pharmaceutical, Inc.
Life Laboratories, Inc.
Linden Laboratories, Inc., Subsidiary of
Chromalloy American Corp.
Luitpold Pharmaceuticals, Inc.
Marshall Pharmacal Corp.
MD Pharmaceutical, Inc.
Medev, Inc.
Mission Pharmacal Co.
M M Mast & Co.
Mutual Pharmaceutical Company, Inc.
Newtron Pharmaceuticals, Inc.
Novartis Pharmaceuticals Corp.
Nylos Trading Co., Inc.
Panray Corp Subsidiary of Ormont Drug
and Chemical Co., Inc.
Parke Davis Division of Warner Lambert
Co.
Pasadena Research Laboratories, Inc.
Penick Corp.
Person and Covey, Inc.
Pfizer Co.
Pfizer, Inc.
Pharmaceutical Associates, Inc.
Pharmacia and Upjohn Co.
Pharmadyne Laboratories, Inc.
Pharmavite Pharmaceuticals
Phoenix Laboratories, Inc.
Polfa Pharmaceutical Works
Premo Pharmaceutical Laboratories, Inc.
Purepac Pharmaceutical Co.
Rachelle Laboratories Italia SpA
Reed and Carnrick Division of Block
Drug Co., Inc.
Rexar Pharmacal
Richlyn Laboratories, Inc.
Robinson Laboratories, Inc.
Roussel Corp.
Rovers Pharmacal, Inc.
RP Scherer Corp.
Sandoz, Inc.
Scherer Laboratories, Inc.
Schering Corp. Subsidiary of Schering
Plough Corp.
Smith Kline and French Laboratory Co.
Subsidiary of SmithKline Beckman
Societa Italiana Prodotti Schering
Sperti Drug Products, Inc.
Stayner Corp.
Steri Med, Inc. Subsidiary of Ketchum
Laboratories, Inc.
Tablicaps, Inc.
Tera Pharmaceuticals, Inc.
Teva Pharmaceuticals USA, Inc.
Titan Pharmacal, Co.
Travenol Laboratories, Inc.
Valeant Pharmaceuticals International
Watson Laboratories, Inc.
Western Research Laboratories, Inc.
West-Ward Pharmaceutical Corp.
Wharton Laboratories, Inc., Division of
US Ethicals
Whiteworth Towne Paulsen, Inc.
Wyeth Ayerst Laboratories
Zenith Laboratories, Inc.
TABLE 1—ABBREVIATED NEW DRUG APPLICATION (ANDA) NUMBERS WITH PRODUCT NAMES
pmangrum on DSK3VPTVN1PROD with NOTICES
ANDA No.
60881
60913
60919
60965
61046
61091
61093
61097
61099
61102
61114
61116
61117
61118
61119
61120
61121
61142
61144
61145
61152
61170
61171
61191
61192
61194
61197
61382
61420
61422
61423
61428
61429
61430
61431
61432
61433
61440
61442
61556
61564
61565
61570
Product name
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
VerDate Mar<15>2010
14:34 Jun 13, 2012
Jkt 226001
Tetracycline hydrochloride.
Dicloxacillin sodium.
Neomycin sulfate; bacitracin.
Neomycin sulfate; polymyxin b sulfates; bacitracin.
Penicillin g sodium.
Phenethicillin potassium.
Penicillin g potassium.
Troleandomycin.
Doxycycline hyclate.
Oxytetracycline calcium.
Chlortetracycline hydrochloride.
Ampicillin trihydrate.
Phenethicillin potassium.
Cloxacillin sodium.
Dicloxacillin sodium.
Tetracycline.
Tetracycline phosphate.
Penicillin g potassium.
Amphotericin b.
Penicillin g potassium.
Tetracycline hydrochloride.
Bacitracin.
Bacitracin zinc.
Tetracycline hydrochloride.
Tetracycline hydrochloride.
Paromomycin sulfate.
Tetracycline hydrochloride.
Ampicillin trihydrate.
Tetracycline.
Oxytetracycline hydrochloride.
Oxytetracycline.
Chloramphenicol palmitate.
Tetracycline.
Chloramphenicol.
Chloramphenicol.
Chloramphenicol sodium succinate.
Chloramphenicol sodium succinate.
Tetracycline hydrochloride.
Erythromycin estolate.
Tetracycline.
Methacycline hydrochloride.
Paromomycin sulfate.
Hetacillin.
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
35693
E:\FR\FM\14JNN1.SGM
14JNN1
35694
Federal Register / Vol. 77, No. 115 / Thursday, June 14, 2012 / Notices
TABLE 1—ABBREVIATED NEW DRUG APPLICATION (ANDA) NUMBERS WITH PRODUCT NAMES—Continued
pmangrum on DSK3VPTVN1PROD with NOTICES
ANDA No.
61581
61582
61597
61604
61608
61629
61630
61631
61749
61750
61751
61754
61775
61777
61778
61779
61784
61795
61796
61797
61804
61824
61825
61843
61844
61845
61852
61993
62016
62019
62020
62344
80004
80088
80200
80313
80350
80351
80359
80452
80456
80501
80559
80560
80561
80616
80676
80840
80943
80947
80956
80985
83002
83003
83004
83005
83006
83007
83114
83133
83134
83197
83203
83208
83233
83243
83258
83259
83268
83269
83293
83311
Product name
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
VerDate Mar<15>2010
14:34 Jun 13, 2012
Jkt 226001
Tetracycline hydrochloride.
Tetracycline.
Ampicillin trihydrate.
Ampicillin sodium.
Tetracycline hydrochloride.
Penicillin g benzathine.
Streptomycin sulfate.
Dihydrostreptomycin sulfate.
Dicloxacillin sodium.
Ampicillin trihydrate.
Doxycycline hyclate.
Griseofulvin.
Tetracycline.
Mitomycin.
Erythromycin.
Erythromycin stearate.
Tetracycline hydrochloride.
Oxacillin sodium.
Oxacillin sodium.
Methicillin sodium.
Carbenicillin indanyl sodium.
Tetracycline.
Tetracycline.
Penicillin v potassium.
Ampicillin.
Ampicillin trihydrate.
Tetracycline phosphate complex.
Cloxacillin sodium.
Amoxicillin trihydrate.
Tetracycline hydrochloride.
Tetracycline phosphate.
Cloxacillin sodium.
Propylthiouracil.
Sulfadiazine.
Succinylcholine chloride.
Methyltestosterone.
Prednisone.
Prednisolone.
Prednisone.
Hydrocortisone.
Hydrocortisone.
Diphenhydramine hydrochloride.
Cyanocobalamin.
Pyridoxine hydrochloride.
Thiamine hydrochloride.
Cyanocobalamin.
Testosterone propionate.
Propylthiouracil.
Vitamin a palmitate.
Aminosalicylate sodium.
Vitamin d.
Vitamin a.
Diethylstilbestrol.
Diethylstilbestrol.
Diethylstilbestrol.
Diethylstilbestrol.
Diethylstilbestrol.
Diethylstilbestrol.
Vitamin a palmitate.
Folic acid.
Vitamin a.
Propoxyphene hydrochloride.
Niacin.
Cortisone acetate.
Hydrocortisone acetate.
Chlorpheniramine maleate.
Butabarbital sodium.
Pentobarbital sodium.
Butabarbital sodium.
Butabarbital sodium.
Propoxyphene hydrochloride.
Vitamin a palmitate.
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
E:\FR\FM\14JNN1.SGM
14JNN1
Federal Register / Vol. 77, No. 115 / Thursday, June 14, 2012 / Notices
TABLE 1—ABBREVIATED NEW DRUG APPLICATION (ANDA) NUMBERS WITH PRODUCT NAMES—Continued
pmangrum on DSK3VPTVN1PROD with NOTICES
ANDA No.
83321
83335
83343
83374
83394
83421
83439
83444
83454
83494
83503
83537
83553
83562
83578
83674
83675
83676
83756
83772
83864
83865
83867
83880
83912
83926
83929
83940
83958
83960
83974
84008
84009
84016
84027
84073
84080
84097
84237
84257
84262
84263
84293
84298
84311
84365
84382
84410
84428
84459
84485
84552
84559
84632
84670
84671
84672
84695
84736
84846
84856
84871
84906
84979
85033
85115
85170
85174
85185
85207
85242
85258
Product name
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
VerDate Mar<15>2010
14:34 Jun 13, 2012
Jkt 226001
Vitamin a palmitate.
Prednisolone acetate.
Meprobamate.
Estrogens, esterified.
Chlorpheniramine maleate.
Probenecid.
Quinidine sulfate.
Rauwolfia serpentina.
Lidocaine.
Meprobamate.
Negatol.
Secobarbital sodium.
Procainamide hydrochloride.
Prednisolone acetate.
Butabarbital sodium.
Diphenhydramine hydrochloride.
Prednisolone.
Prednisone.
Piperazine citrate.
Pyridoxine hydrochloride.
Secobarbital sodium.
Promethazine hydrochloride.
Rauwolfia serpentina.
Propoxyphene hydrochloride.
Vitamin a palmitate.
Ergotamine tartrate; caffeine.
Cortisone acetate.
Diethylstilbestrol.
Propylthiouracil.
Prednisolone.
Trihexyphenidyl hydrochloride.
Chlorpheniramine maleate.
Prednisone.
Dextroamphetamine hydrochloride.
Promethazine hydrochloride.
Benzthiazide.
Promethazine hydrochloride.
Dicyclomine hydrochloride.
Niacin.
Dicyclomine hydrochloride.
Phenylbutazone.
Dimenhydrinate.
Dicyclomine hydrochloride.
Hydrochlorothiazide.
Phenylbutazone.
Dexamethasone sodium phosphate.
Meclizine hydrochloride.
Trichlormethiazide.
Propantheline bromide.
Propylthiouracil.
Phentermine hydrochloride.
Aminophylline.
Theophylline.
Aminophylline.
Chlordiazepoxide.
Chlordiazepoxide.
Chlordiazepoxide.
Phentermine hydrochloride.
Rescinnamine.
Methocarbamol.
Cortisone acetate.
Prednisolone acetate.
Reserpine; hydrochlorothiazide.
Hydrocortisone.
Methocarbamol.
Prednisone.
Prednisolone.
Cortisone acetate.
Diethylpropion hydrochloride.
Reserpine.
Chlordiazepoxide hydrochloride.
Chlordiazepoxide.
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
E:\FR\FM\14JNN1.SGM
14JNN1
35695
35696
Federal Register / Vol. 77, No. 115 / Thursday, June 14, 2012 / Notices
TABLE 1—ABBREVIATED NEW DRUG APPLICATION (ANDA) NUMBERS WITH PRODUCT NAMES—Continued
pmangrum on DSK3VPTVN1PROD with NOTICES
ANDA No.
85259
85270
85280
85281
85308
85325
85360
85405
85412
85419
85439
85442
85489
85516
85576
85590
85592
85613
85647
85649
85678
85680
85696
85707
85716
85717
85725
85730
85731
85760
85774
85776
85806
85807
85808
85812
85901
85918
85942
85943
85946
85947
85948
85949
85950
85954
85955
85972
86068
86111
86115
86125
86128
86131
86207
86211
86253
86254
86279
86286
86288
86316
86317
86318
86319
86320
86321
86322
86324
86326
86327
86334
Product name
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
VerDate Mar<15>2010
14:34 Jun 13, 2012
Jkt 226001
Chlordiazepoxide.
Methyltestosterone.
Chlordiazepoxide hydrochloride.
Chlordiazepoxide hydrochloride.
Phenytoin sodium.
Methylprednisolone.
Chlordiazepoxide hydrochloride.
Perphenazine.
Tripelennamine hydrochloride.
Quinidine sulfate.
Butalbital; aspirin; phenacetin; caffeine.
Chlordiazepoxide hydrochloride.
Probenecid.
Theophylline.
Estradiol.
Oxyphenbutazone.
Brompheniramine maleate.
Phendimetrazine tartrate.
Amitriptyline hydrochloride.
Amitriptyline hydrochloride.
Amitriptyline hydrochloride.
Amitriptyline hydrochloride.
Isoniazid; pyridoxine hydrochloride.
Isopropamide iodide.
Hydralazine hydrochloride.
Hydralazine hydrochloride.
Phendimetrazine tartrate.
Cyanocobalamin.
Phentermine hydrochloride.
Chlorothiazide.
Methyltestosterone.
Methyltestosterone.
Reserpine; hydralazine hydrochloride; hydrochlorotiazide.
Meclizine hydrochloride.
Meclizine hydrochloride.
Propoxyphene hydrochloride.
Imipramine hydrochloride.
Ergotamine tartrate; caffeine.
Amitriptyline hydrochloride.
Triamcinolone acetonide.
Amitriptyline hydrochloride.
Amitriptyline hydrochloride.
Amitriptyline hydrochloride.
Amitriptyline hydrochloride.
Amitriptyline hydrochloride.
Methyltestosterone.
Methyltestosterone.
Acetaminophen; salicylamide; caffeine; codeine phosphate.
Triamcinolone acetonide.
Amodiaquine hydrochloride.
Bethanechol chloride.
Quinidine sulfate.
Chlorpromazine.
Acetazolamide.
Hydrocortisone acetate.
Phendimetrazine tartrate.
Trihexyphenidyl hydrochloride.
Chlorothiazide.
Hydrochlorothiazide.
Butalbital; aspirin; phenacetin; caffeine.
Amitriptyline hydrochloride.
Orphenadrine citrate.
Diphenoxylate hydrochloride; atropine sulfate.
Hydrochlorothiazide.
Hydrochlorothiazide.
Methocarbamol.
Methocarbamol.
Prednisone.
Prednisone.
Butalbital; aspirin; phenacetin; caffeine.
Trifluoperazine hydrochloride.
Hydrocortisone.
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
E:\FR\FM\14JNN1.SGM
14JNN1
Federal Register / Vol. 77, No. 115 / Thursday, June 14, 2012 / Notices
TABLE 1—ABBREVIATED NEW DRUG APPLICATION (ANDA) NUMBERS WITH PRODUCT NAMES—Continued
pmangrum on DSK3VPTVN1PROD with NOTICES
ANDA No.
86343
86345
86354
86377
86400
86401
86404
86407
86411
86412
86430
86431
86436
86437
86438
86443
86447
86476
86510
86515
86529
86555
86563
86564
86565
86566
86581
86591
86625
86627
86629
86630
86634
86644
86647
86650
86654
86655
86657
86658
86665
86667
86668
86669
86670
86671
86674
86675
86685
86687
86692
86694
86696
86701
86703
86704
86706
86708
86709
86721
86770
86773
86774
86775
86776
86777
86779
86782
86783
86784
86785
86786
Product name
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
VerDate Mar<15>2010
14:34 Jun 13, 2012
Jkt 226001
Thioridazine hydrochloride.
Thioridazine hydrochloride.
Thioridazine hydrochloride.
Hydrochlorothiazide.
Hydrocortisone acetate.
Hydrocortisone acetate.
Phendimetrazine tartrate.
Phendimetrazine tartrate.
Dimenhydrinate.
Dicyclomine hydrochloride.
Phendimetrazine;adipic acid.
Phendimetrazine.
Homatropine methylbromide.
Homatropine hydrobromide.
Trifluoperazine hydrochloride.
Trifluoperazine hydrochloride.
Trifluoperazine hydrochloride.
Diazepam.
Phentermine hydrochloride.
Phentermine hydrochloride.
Dicyclomine hydrochloride; phenobarbital.
Phendimetrazine tartrate.
Dicyclomine hydrochloride; phenobarbital.
Phenobarbital; atropine sulfate; hyoscyamine sulfate; hyscyamine hydrobromide.
Phenobarbital; hyoscyamine sulfate; atropine sulfate; scopolamine hydrobromide.
Dicyclomine hydrochloride; phenobarbital.
Chlordiazepoxide hydrochloride; clidinium bromide.
Phenobarbital; hyoscyamine sulfate; atropine sulfate; scopolamine hydrobromide.
Dicyclomine hydrochloride.
Meprobamate; tridihexethyl chloride.
Meprobamate; tridihexethyl chloride.
Piperidolate hydrochloride; phenobarbital.
Chlordiazepoxide hydrochloride; clidinium bromide.
Piperidolate hydrochloride.
Chlordiazepoxide hydrochloride; clidinium bromide.
Anisotropine methylbromide; phenobarbital.
Meprobamate; tridihexethyl chloride.
Atropine sulfate; hyoscyamine sulfate; phenobarbital; scopolamine hydrobromide.
Phenobarbital; atropine sulfate; hyoscyamine sulfate; scopolamine hydrobromide.
Meprobamate; tridihexethyl chloride.
Phenobarbital; atropine sulfate; hyoscyamine sulfate; scopolamine hydrobromide.
Chlordiazepoxide hydrochloride; clidinium bromide.
Phenobarbital; belladonna alkaloid malates, l-.
Dicyclomine hydrochloride.
Atropine sulfate; hyoscyamine sulfate; phenobarbital; scopolamine hydrobromide.
Phenobarbital; hyoscyamine sulfate.
Meprobamate; tridihexethyl chloride.
Butabarbital sodium; simethicone; atropine sulfate; hyoscyamine sulfate; scopoamine.
Chlordiazepoxide hydrochloride; clidinium bromide.
Phenobarbital; belladonna extract.
Amobarbital; belladonna.
Oxyphencyclimine hydrochloride; phenobarbital.
Phenobarbital; hyoscyamine sulfate; atropine sulfate; scopolamine hydrobromide.
Atropine sulfate; phenobarbital.
Phenobarbital; hyoscyamine sulfate; atropine sulfate; scopolamine hydrobromide.
Phenobarbital; hyoscyamine sulfate; atropine sulfate; scopolamine hydrobromide.
Meprobamate; tridihexethyl chloride.
Cyproheptadine hydrochloride.
Meprobamate; tridihexethyl chloride.
Procainamide hydrochloride.
Nitroglycerin.
Triamcinolone diacetate.
Erythrityl tetranitrate.
Isosorbide dinitrate.
Pentaerythritol tetranitrate.
Nitroglycerin.
Nitroglycerin.
Nitroglycerin.
Isosorbide dinitrate.
Pentaerythritol tetranitrate.
Pentaerythritol tetranitrate.
Isosorbide dinitrate.
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
E:\FR\FM\14JNN1.SGM
14JNN1
35697
35698
Federal Register / Vol. 77, No. 115 / Thursday, June 14, 2012 / Notices
TABLE 1—ABBREVIATED NEW DRUG APPLICATION (ANDA) NUMBERS WITH PRODUCT NAMES—Continued
ANDA No.
86789
86794
86799
86838
86839
86868
86882
86897
86921
86970
86976
86991
86999
87000
87041
87064
87069
87096
87097
87098
87099
87106
87112
87116
87123
87124
87125
87134
87166
87172
87198
87379
87443
Product name
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
........................................................
Estradiol valerate.
Dipyridamole.
Atropine sulfate; phenobarbital.
Pentaerythritol tetranitrate.
Isosorbide dinitrate.
Chlorpromazine hydrochloride.
Hydrocortisone.
Phenobarbital; hyoscyamine hydrobromide; atropine sulfate; scopolamine hydrobromide.
Chlordiazepoxide hydrochloride; clidinum bromide.
Aminophylline.
Doxylamine succinate; pyridoxine hydrochloride.
Probenecid.
Butalbital; aspirin; phenacetin; caffeine.
Hydralazine hydrochloride.
Phendimetrazine tartrate.
Piperazine citrate.
Sulfisoxazole acetyl.
Phentermine hydrochloride.
Phentermine hydrochloride.
Phentermine hydrochloride.
Phentermine hydrochloride.
Ergotamine tartrate; caffeine.
Spironolactone.
Reserpine; chlorothiazide.
Benzthiazide.
Benzthiazide.
Diphenhydramine hydrochloride.
Promethazine hydrochloride.
Phentolamine hydrochloride.
Theophylline.
Belladonna alkaloid malates, l-; phenobarbital.
Quinidine gluconate.
Homatropine methylbromide; phenobarbital.
Dated: June 8, 2012.
Leslie Kux,
Assistant Commissioner for Policy.
Authority: Section 1111 of the Public
Health Service (PHS) Act, 42 U.S.C. 300b–10,
as amended. The SACHDNC also is governed
by the provisions of Public Law 92–463, as
amended (5 U.S.C. App. 2), and 41 CFR part
102–3, which sets forth standards for the
formation and use of advisory committees.
[FR Doc. 2012–14476 Filed 6–13–12; 8:45 am]
BILLING CODE 4160–01–P
Health Resources and Services
Administration
Secretary’s Advisory Committee on
Heritable Disorders in Newborns and
Children
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services (HHS).
AGENCY:
Notice of Request for
Nominations of Non-Voting Secretary’s
Advisory Committee on Heritable
Disorders in Newborns and Children
(SACHDNC) members to serve as
representatives of organizations or
interest groups.
pmangrum on DSK3VPTVN1PROD with NOTICES
ACTION:
HRSA is requesting
applications to fill three (3) vacancies
for non-voting organizational
representatives on the SACHDNC.
SUMMARY:
VerDate Mar<15>2010
14:34 Jun 13, 2012
Jkt 226001
The agency must receive written
applications from nominees (including a
letter of support from an appropriate
official of the organization with which
affiliated) or the nominee’s organization,
on or before August 1, 2012.
ADDRESSES: Submit written applications
to Sara Copeland, M.D., Designated
Federal Official (DFO), SACHDNC; and,
Chief, Genetic Services Branch,
Maternal and Child Health Bureau,
Health Resources and Services
Administration, Room 18A–19,
Parklawn Building, 5600 Fishers Lane,
Rockville, Maryland 20857.
Applications may also be sent to
Screening@hrsa.hhs.gov.
DATES:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Debi
Sarkar, M.P.H., Genetic Services Branch,
Maternal and Child Health Bureau,
HRSA, at dsarkar@hrsa.gov or
(301) 443–1080. A copy of the
SACHDNC Charter and list of the
current membership may be obtained by
contacting Ms. Sarkar or by accessing
FOR FURTHER INFORMATION CONTACT:
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
the SACHDNC Web site at https://
www.hrsa.gov/advisorycommittees/
mchbadvisory/heritabledisorders/.
SUPPLEMENTARY INFORMATION: The
SACHDNC is directed to review and
report regularly on newborn and
childhood screening practices for
heritable disorders and recommend
improvements in the national newborn
and childhood heritable screening
programs.
The SACHDNC provides the Secretary
with recommendations, advice, and
technical information regarding the
application of technologies, policies,
guidelines, and standards for: (a)
Effectively reducing morbidity and
mortality in newborns and children
having, or at risk for, heritable
disorders; and (b) enhancing the ability
of the State and local health agencies to
provide for newborn and child
screening, counseling, and health care
services for newborns and children
having, or at risk for, heritable
disorders.
Specifically, HRSA is requesting
applications for three (3) non-voting
organizational representatives to serve
on the SACHDNC: Two (2) at large
representatives of a public health
constituency, medical professional
E:\FR\FM\14JNN1.SGM
14JNN1
Agencies
[Federal Register Volume 77, Number 115 (Thursday, June 14, 2012)]
[Notices]
[Pages 35691-35698]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-14476]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2012-N-0517]
Notice of Withdrawal of Certain Unapproved Abbreviated New Drug
Applications
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA or the Agency) is
announcing its intention to deem to be withdrawn any abbreviated new
drug applications (ANDAs) that have been determined to be incomplete
and as to which the ANDA applicant has not communicated with FDA since
July 8, 1991. Each of these applications will be
[[Page 35692]]
deemed to have been withdrawn voluntarily by the applicant unless the
applicant informs the Agency in writing that it intends to actively
pursue approval of the application(s) (see DATES).
DATES: The applicant of an ANDA covered by this notice that intends to
actively pursue approval of its application must submit a written
notification to FDA by August 13, 2012.
ADDRESSES: Applicants should submit written notifications to the ANDA
archival file to the Office of Generic Drugs, Center for Drug
Evaluation and Research, Food and Drug Administration, Document Control
Room, MPN7, 7620 Standish Pl., Rockville, MD 20855. A copy of written
notifications should also be submitted to Thomas Hinchliffe, Center for
Drug Evaluation and Research (HFD-617), Food and Drug Administration,
7500 Standish Pl., rm. N-142, MPN2, Rockville, MD 20855, FAX: 240-276-
8440, email: inactiveandas@fda.hhs.gov.
FOR FURTHER INFORMATION CONTACT: Thomas Hinchliffe, Center for Drug
Evaluation and Research (HFD-617), Food and Drug Administration, 7500
Standish Pl., rm. N-142, MPN2, Rockville, MD 20855, 240-276-8433, FAX:
240-276-9310, email: inactiveandas@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
FDA has identified 364 ANDAs for which FDA has not received any
communication from the ANDA applicant since July 8, 1991, or earlier
(Inactive ANDAs). (See section IV of this document for the list of
Inactive ANDAs). For purposes of this document, the term ``applicant''
includes any successor in interest. FDA's regulations provide that the
Agency will consider withdrawn any application for which the applicant
has not contacted the Agency about its intention regarding such
application within 1 year after issuance of a complete response letter
to the applicant (see 21 CFR 314.110(c)). The Inactive ANDAs, however,
predate, and consequently are not subject to this regulation.
Therefore, the Inactive ANDAs have not been deemed withdrawn although
there has been no communication from the applicants since July 8, 1991,
or earlier.
II. Withdrawal of Inactive ANDAs
At this time, the Agency is announcing its intention to deem all
Inactive ANDAs to have been voluntarily withdrawn by the respective
applicants as of August 13, 2012, unless the applicant informs the
Agency in writing by the date set forth under DATES in this document of
its intent to actively pursue approval of the application. Therefore,
in the absence of a written notice with respect to an Inactive ANDA by
the date specified in this notice, the ANDA will be considered to have
been withdrawn by the applicant. No further notice of the withdrawal of
Inactive ANDAs will be provided. Withdrawal of an unapproved
application is without prejudice to resubmission of that application
(21 CFR 314.65). Because of the length of time that has passed since
these applications were submitted, FDA strongly recommends that any
applicant intending to actively pursue approval review the application
carefully to determine whether it satisfies current ANDA requirements
(21 CFR part 314).
III. Action by the Applicant
If the applicant wishes to actively pursue approval of an Inactive
ANDA and does not wish the application to be deemed by FDA to have been
voluntarily withdrawn, the applicant must inform the Agency in writing
within the time specified in this document. Written notice should be
provided to Thomas Hinchliffe and the Office of Generic Drugs (see
ADDRESSES).
FDA also asks any applicant that agrees to consider its application
to be voluntarily withdrawn to send a written notice to Thomas
Hinchliffe and the Office of Generic Drugs (see ADDRESSES) to confirm
that agreement. However, applicants of Inactive ANDAs covered by this
notice who wish their applications to be withdrawn are not required to
provide written notice to FDA.
IV. Details About Inactive ANDAs
Information about the Inactive ANDAs is listed in this section of
the document. To protect applicant confidentiality, this notice lists
the application number and drug name for each Inactive ANDA and
separately lists the name of the applicant as shown in the information
on file with FDA, without linking identified applicants with specific
applications or drug names. In some cases, the identified applicants
may no longer exist as ongoing business entities. If an identified
applicant is unsure which application(s) belong to it (if any), it may
contact Thomas Hinchliffe (see FOR FURTHER INFORMATION CONTACT).
Alphabetical List of Abbreviated New Drug Application Applicants
1st Texas Pharmaceuticals, Inc., Subsidiary of Scherer Laboratories
Inc.
Abraxis Pharmaceutical Products
AH Robins, Co.
Alpharma US Pharmaceuticals Division
Ambix Laboratories Division of Organics Corp America
Ankerfarm SpA
Ankerman SpA
Antibioticos SA
Arcum Pharmaceutical Corp.
Banner Pharmacaps, Inc.
Barr Laboratories, Inc.
Baxter Healthcare Corp.
Beecham Laboratories Division of Beecham Inc.
Beecham SA
Bel Mar Laboratories, Inc.
Biocraft Laboratories, Inc.
Biometric Testing, Inc.
Boots Laboratories, Inc., Division of Boots Pharmaceuticals Inc.
Bristol Laboratories, Inc., Division of Bristol Myers Co.
Bristol Myers Co. International Division
Bristol Myers Industrial Division
Bristol Myers Squibb
Camall Co., Inc.
Carlo Erba SpA
Century Pharmaceuticals, Inc.
Chemibiotic Ireland, Ltd.
Chromalloy Laboratories Division of Chromalloy Pharmaceuticals, Inc.
Clifford Chemical Corp.
CM Bundy Co.
Comatic Laboratories, Inc.
Credo Co.
Delco Chemical Co., Inc.
Dell Laboratories, Inc.
Dermasave Laboratories, Inc.
Dista Products Co. Division of Eli Lilly & Co.
DM Pharmaceuticals, Inc.
Dorasol Laboratories
Dunhall Pharmaceuticals, Inc.
ER Squibb and Sons Pharmaceutical Laboratories
Ersana, Inc., Subsidiary of ER Squibb and Sons
Everylife
Fallek Products Co., Inc.
Farmila Farmaceutica
Faton Pharmaceuticals, Inc.
Fermion Oy
Ferndale Laboratories, Inc.
Fisons Corp.
Forest Laboratories, Inc.
Forest Pharmaceuticals, Inc.
Forrest Laboratories, Inc.
G & W Co.
Glenwood Laboratories, Inc.
Global Pharmaceutical Corp.
Gruppo Lepetit SpA Subsidiary of Merrell Dow Pharmaceuticals, Inc.
Heather Drug Co., Inc.
Herald Pharmacal, Inc.
Hoffmann La Roche, Inc.
ICI Ltd.
Ingram Pharmaceutical Co.
Inwood Laboratories, Inc., Subsidiary of Forest Laboratories, Inc.
[[Page 35693]]
ISF
Kasar Laboratories Division of Kasar Co.
Kasco EFCO Laboratories, Inc., Division of Byk Gulden, Inc.
KV Pharmaceutical, Co.
Lannett Co, Inc.
Lederle Laboratories Division of American Cyanamid Co.
Leiner Health Products, Inc.
Lemmon Co. Subsidiary of Tag Pharmaceutical, Inc.
Life Laboratories, Inc.
Linden Laboratories, Inc., Subsidiary of Chromalloy American Corp.
Luitpold Pharmaceuticals, Inc.
Marshall Pharmacal Corp.
MD Pharmaceutical, Inc.
Medev, Inc.
Mission Pharmacal Co.
M M Mast & Co.
Mutual Pharmaceutical Company, Inc.
Newtron Pharmaceuticals, Inc.
Novartis Pharmaceuticals Corp.
Nylos Trading Co., Inc.
Panray Corp Subsidiary of Ormont Drug and Chemical Co., Inc.
Parke Davis Division of Warner Lambert Co.
Pasadena Research Laboratories, Inc.
Penick Corp.
Person and Covey, Inc.
Pfizer Co.
Pfizer, Inc.
Pharmaceutical Associates, Inc.
Pharmacia and Upjohn Co.
Pharmadyne Laboratories, Inc.
Pharmavite Pharmaceuticals
Phoenix Laboratories, Inc.
Polfa Pharmaceutical Works
Premo Pharmaceutical Laboratories, Inc.
Purepac Pharmaceutical Co.
Rachelle Laboratories Italia SpA
Reed and Carnrick Division of Block Drug Co., Inc.
Rexar Pharmacal
Richlyn Laboratories, Inc.
Robinson Laboratories, Inc.
Roussel Corp.
Rovers Pharmacal, Inc.
RP Scherer Corp.
Sandoz, Inc.
Scherer Laboratories, Inc.
Schering Corp. Subsidiary of Schering Plough Corp.
Smith Kline and French Laboratory Co. Subsidiary of SmithKline Beckman
Societa Italiana Prodotti Schering
Sperti Drug Products, Inc.
Stayner Corp.
Steri Med, Inc. Subsidiary of Ketchum Laboratories, Inc.
Tablicaps, Inc.
Tera Pharmaceuticals, Inc.
Teva Pharmaceuticals USA, Inc.
Titan Pharmacal, Co.
Travenol Laboratories, Inc.
Valeant Pharmaceuticals International
Watson Laboratories, Inc.
Western Research Laboratories, Inc.
West-Ward Pharmaceutical Corp.
Wharton Laboratories, Inc., Division of US Ethicals
Whiteworth Towne Paulsen, Inc.
Wyeth Ayerst Laboratories
Zenith Laboratories, Inc.
Table 1--Abbreviated New Drug Application (ANDA) Numbers With Product
Names
------------------------------------------------------------------------
ANDA No. Product name
------------------------------------------------------------------------
60881............................................. Tetracycline
hydrochloride.
60913............................................. Dicloxacillin
sodium.
60919............................................. Neomycin sulfate;
bacitracin.
60965............................................. Neomycin sulfate;
polymyxin b
sulfates;
bacitracin.
61046............................................. Penicillin g sodium.
61091............................................. Phenethicillin
potassium.
61093............................................. Penicillin g
potassium.
61097............................................. Troleandomycin.
61099............................................. Doxycycline hyclate.
61102............................................. Oxytetracycline
calcium.
61114............................................. Chlortetracycline
hydrochloride.
61116............................................. Ampicillin
trihydrate.
61117............................................. Phenethicillin
potassium.
61118............................................. Cloxacillin sodium.
61119............................................. Dicloxacillin
sodium.
61120............................................. Tetracycline.
61121............................................. Tetracycline
phosphate.
61142............................................. Penicillin g
potassium.
61144............................................. Amphotericin b.
61145............................................. Penicillin g
potassium.
61152............................................. Tetracycline
hydrochloride.
61170............................................. Bacitracin.
61171............................................. Bacitracin zinc.
61191............................................. Tetracycline
hydrochloride.
61192............................................. Tetracycline
hydrochloride.
61194............................................. Paromomycin sulfate.
61197............................................. Tetracycline
hydrochloride.
61382............................................. Ampicillin
trihydrate.
61420............................................. Tetracycline.
61422............................................. Oxytetracycline
hydrochloride.
61423............................................. Oxytetracycline.
61428............................................. Chloramphenicol
palmitate.
61429............................................. Tetracycline.
61430............................................. Chloramphenicol.
61431............................................. Chloramphenicol.
61432............................................. Chloramphenicol
sodium succinate.
61433............................................. Chloramphenicol
sodium succinate.
61440............................................. Tetracycline
hydrochloride.
61442............................................. Erythromycin
estolate.
61556............................................. Tetracycline.
61564............................................. Methacycline
hydrochloride.
61565............................................. Paromomycin sulfate.
61570............................................. Hetacillin.
[[Page 35694]]
61581............................................. Tetracycline
hydrochloride.
61582............................................. Tetracycline.
61597............................................. Ampicillin
trihydrate.
61604............................................. Ampicillin sodium.
61608............................................. Tetracycline
hydrochloride.
61629............................................. Penicillin g
benzathine.
61630............................................. Streptomycin
sulfate.
61631............................................. Dihydrostreptomycin
sulfate.
61749............................................. Dicloxacillin
sodium.
61750............................................. Ampicillin
trihydrate.
61751............................................. Doxycycline hyclate.
61754............................................. Griseofulvin.
61775............................................. Tetracycline.
61777............................................. Mitomycin.
61778............................................. Erythromycin.
61779............................................. Erythromycin
stearate.
61784............................................. Tetracycline
hydrochloride.
61795............................................. Oxacillin sodium.
61796............................................. Oxacillin sodium.
61797............................................. Methicillin sodium.
61804............................................. Carbenicillin
indanyl sodium.
61824............................................. Tetracycline.
61825............................................. Tetracycline.
61843............................................. Penicillin v
potassium.
61844............................................. Ampicillin.
61845............................................. Ampicillin
trihydrate.
61852............................................. Tetracycline
phosphate complex.
61993............................................. Cloxacillin sodium.
62016............................................. Amoxicillin
trihydrate.
62019............................................. Tetracycline
hydrochloride.
62020............................................. Tetracycline
phosphate.
62344............................................. Cloxacillin sodium.
80004............................................. Propylthiouracil.
80088............................................. Sulfadiazine.
80200............................................. Succinylcholine
chloride.
80313............................................. Methyltestosterone.
80350............................................. Prednisone.
80351............................................. Prednisolone.
80359............................................. Prednisone.
80452............................................. Hydrocortisone.
80456............................................. Hydrocortisone.
80501............................................. Diphenhydramine
hydrochloride.
80559............................................. Cyanocobalamin.
80560............................................. Pyridoxine
hydrochloride.
80561............................................. Thiamine
hydrochloride.
80616............................................. Cyanocobalamin.
80676............................................. Testosterone
propionate.
80840............................................. Propylthiouracil.
80943............................................. Vitamin a palmitate.
80947............................................. Aminosalicylate
sodium.
80956............................................. Vitamin d.
80985............................................. Vitamin a.
83002............................................. Diethylstilbestrol.
83003............................................. Diethylstilbestrol.
83004............................................. Diethylstilbestrol.
83005............................................. Diethylstilbestrol.
83006............................................. Diethylstilbestrol.
83007............................................. Diethylstilbestrol.
83114............................................. Vitamin a palmitate.
83133............................................. Folic acid.
83134............................................. Vitamin a.
83197............................................. Propoxyphene
hydrochloride.
83203............................................. Niacin.
83208............................................. Cortisone acetate.
83233............................................. Hydrocortisone
acetate.
83243............................................. Chlorpheniramine
maleate.
83258............................................. Butabarbital sodium.
83259............................................. Pentobarbital
sodium.
83268............................................. Butabarbital sodium.
83269............................................. Butabarbital sodium.
83293............................................. Propoxyphene
hydrochloride.
83311............................................. Vitamin a palmitate.
[[Page 35695]]
83321............................................. Vitamin a palmitate.
83335............................................. Prednisolone
acetate.
83343............................................. Meprobamate.
83374............................................. Estrogens,
esterified.
83394............................................. Chlorpheniramine
maleate.
83421............................................. Probenecid.
83439............................................. Quinidine sulfate.
83444............................................. Rauwolfia
serpentina.
83454............................................. Lidocaine.
83494............................................. Meprobamate.
83503............................................. Negatol.
83537............................................. Secobarbital sodium.
83553............................................. Procainamide
hydrochloride.
83562............................................. Prednisolone
acetate.
83578............................................. Butabarbital sodium.
83674............................................. Diphenhydramine
hydrochloride.
83675............................................. Prednisolone.
83676............................................. Prednisone.
83756............................................. Piperazine citrate.
83772............................................. Pyridoxine
hydrochloride.
83864............................................. Secobarbital sodium.
83865............................................. Promethazine
hydrochloride.
83867............................................. Rauwolfia
serpentina.
83880............................................. Propoxyphene
hydrochloride.
83912............................................. Vitamin a palmitate.
83926............................................. Ergotamine tartrate;
caffeine.
83929............................................. Cortisone acetate.
83940............................................. Diethylstilbestrol.
83958............................................. Propylthiouracil.
83960............................................. Prednisolone.
83974............................................. Trihexyphenidyl
hydrochloride.
84008............................................. Chlorpheniramine
maleate.
84009............................................. Prednisone.
84016............................................. Dextroamphetamine
hydrochloride.
84027............................................. Promethazine
hydrochloride.
84073............................................. Benzthiazide.
84080............................................. Promethazine
hydrochloride.
84097............................................. Dicyclomine
hydrochloride.
84237............................................. Niacin.
84257............................................. Dicyclomine
hydrochloride.
84262............................................. Phenylbutazone.
84263............................................. Dimenhydrinate.
84293............................................. Dicyclomine
hydrochloride.
84298............................................. Hydrochlorothiazide.
84311............................................. Phenylbutazone.
84365............................................. Dexamethasone sodium
phosphate.
84382............................................. Meclizine
hydrochloride.
84410............................................. Trichlormethiazide.
84428............................................. Propantheline
bromide.
84459............................................. Propylthiouracil.
84485............................................. Phentermine
hydrochloride.
84552............................................. Aminophylline.
84559............................................. Theophylline.
84632............................................. Aminophylline.
84670............................................. Chlordiazepoxide.
84671............................................. Chlordiazepoxide.
84672............................................. Chlordiazepoxide.
84695............................................. Phentermine
hydrochloride.
84736............................................. Rescinnamine.
84846............................................. Methocarbamol.
84856............................................. Cortisone acetate.
84871............................................. Prednisolone
acetate.
84906............................................. Reserpine;
hydrochlorothiazide
.
84979............................................. Hydrocortisone.
85033............................................. Methocarbamol.
85115............................................. Prednisone.
85170............................................. Prednisolone.
85174............................................. Cortisone acetate.
85185............................................. Diethylpropion
hydrochloride.
85207............................................. Reserpine.
85242............................................. Chlordiazepoxide
hydrochloride.
85258............................................. Chlordiazepoxide.
[[Page 35696]]
85259............................................. Chlordiazepoxide.
85270............................................. Methyltestosterone.
85280............................................. Chlordiazepoxide
hydrochloride.
85281............................................. Chlordiazepoxide
hydrochloride.
85308............................................. Phenytoin sodium.
85325............................................. Methylprednisolone.
85360............................................. Chlordiazepoxide
hydrochloride.
85405............................................. Perphenazine.
85412............................................. Tripelennamine
hydrochloride.
85419............................................. Quinidine sulfate.
85439............................................. Butalbital; aspirin;
phenacetin;
caffeine.
85442............................................. Chlordiazepoxide
hydrochloride.
85489............................................. Probenecid.
85516............................................. Theophylline.
85576............................................. Estradiol.
85590............................................. Oxyphenbutazone.
85592............................................. Brompheniramine
maleate.
85613............................................. Phendimetrazine
tartrate.
85647............................................. Amitriptyline
hydrochloride.
85649............................................. Amitriptyline
hydrochloride.
85678............................................. Amitriptyline
hydrochloride.
85680............................................. Amitriptyline
hydrochloride.
85696............................................. Isoniazid;
pyridoxine
hydrochloride.
85707............................................. Isopropamide iodide.
85716............................................. Hydralazine
hydrochloride.
85717............................................. Hydralazine
hydrochloride.
85725............................................. Phendimetrazine
tartrate.
85730............................................. Cyanocobalamin.
85731............................................. Phentermine
hydrochloride.
85760............................................. Chlorothiazide.
85774............................................. Methyltestosterone.
85776............................................. Methyltestosterone.
85806............................................. Reserpine;
hydralazine
hydrochloride;
hydrochlorotiazide.
85807............................................. Meclizine
hydrochloride.
85808............................................. Meclizine
hydrochloride.
85812............................................. Propoxyphene
hydrochloride.
85901............................................. Imipramine
hydrochloride.
85918............................................. Ergotamine tartrate;
caffeine.
85942............................................. Amitriptyline
hydrochloride.
85943............................................. Triamcinolone
acetonide.
85946............................................. Amitriptyline
hydrochloride.
85947............................................. Amitriptyline
hydrochloride.
85948............................................. Amitriptyline
hydrochloride.
85949............................................. Amitriptyline
hydrochloride.
85950............................................. Amitriptyline
hydrochloride.
85954............................................. Methyltestosterone.
85955............................................. Methyltestosterone.
85972............................................. Acetaminophen;
salicylamide;
caffeine; codeine
phosphate.
86068............................................. Triamcinolone
acetonide.
86111............................................. Amodiaquine
hydrochloride.
86115............................................. Bethanechol
chloride.
86125............................................. Quinidine sulfate.
86128............................................. Chlorpromazine.
86131............................................. Acetazolamide.
86207............................................. Hydrocortisone
acetate.
86211............................................. Phendimetrazine
tartrate.
86253............................................. Trihexyphenidyl
hydrochloride.
86254............................................. Chlorothiazide.
86279............................................. Hydrochlorothiazide.
86286............................................. Butalbital; aspirin;
phenacetin;
caffeine.
86288............................................. Amitriptyline
hydrochloride.
86316............................................. Orphenadrine
citrate.
86317............................................. Diphenoxylate
hydrochloride;
atropine sulfate.
86318............................................. Hydrochlorothiazide.
86319............................................. Hydrochlorothiazide.
86320............................................. Methocarbamol.
86321............................................. Methocarbamol.
86322............................................. Prednisone.
86324............................................. Prednisone.
86326............................................. Butalbital; aspirin;
phenacetin;
caffeine.
86327............................................. Trifluoperazine
hydrochloride.
86334............................................. Hydrocortisone.
[[Page 35697]]
86343............................................. Thioridazine
hydrochloride.
86345............................................. Thioridazine
hydrochloride.
86354............................................. Thioridazine
hydrochloride.
86377............................................. Hydrochlorothiazide.
86400............................................. Hydrocortisone
acetate.
86401............................................. Hydrocortisone
acetate.
86404............................................. Phendimetrazine
tartrate.
86407............................................. Phendimetrazine
tartrate.
86411............................................. Dimenhydrinate.
86412............................................. Dicyclomine
hydrochloride.
86430............................................. Phendimetrazine;adip
ic acid.
86431............................................. Phendimetrazine.
86436............................................. Homatropine
methylbromide.
86437............................................. Homatropine
hydrobromide.
86438............................................. Trifluoperazine
hydrochloride.
86443............................................. Trifluoperazine
hydrochloride.
86447............................................. Trifluoperazine
hydrochloride.
86476............................................. Diazepam.
86510............................................. Phentermine
hydrochloride.
86515............................................. Phentermine
hydrochloride.
86529............................................. Dicyclomine
hydrochloride;
phenobarbital.
86555............................................. Phendimetrazine
tartrate.
86563............................................. Dicyclomine
hydrochloride;
phenobarbital.
86564............................................. Phenobarbital;
atropine sulfate;
hyoscyamine
sulfate; hyscyamine
hydrobromide.
86565............................................. Phenobarbital;
hyoscyamine
sulfate; atropine
sulfate;
scopolamine
hydrobromide.
86566............................................. Dicyclomine
hydrochloride;
phenobarbital.
86581............................................. Chlordiazepoxide
hydrochloride;
clidinium bromide.
86591............................................. Phenobarbital;
hyoscyamine
sulfate; atropine
sulfate;
scopolamine
hydrobromide.
86625............................................. Dicyclomine
hydrochloride.
86627............................................. Meprobamate;
tridihexethyl
chloride.
86629............................................. Meprobamate;
tridihexethyl
chloride.
86630............................................. Piperidolate
hydrochloride;
phenobarbital.
86634............................................. Chlordiazepoxide
hydrochloride;
clidinium bromide.
86644............................................. Piperidolate
hydrochloride.
86647............................................. Chlordiazepoxide
hydrochloride;
clidinium bromide.
86650............................................. Anisotropine
methylbromide;
phenobarbital.
86654............................................. Meprobamate;
tridihexethyl
chloride.
86655............................................. Atropine sulfate;
hyoscyamine
sulfate;
phenobarbital;
scopolamine
hydrobromide.
86657............................................. Phenobarbital;
atropine sulfate;
hyoscyamine
sulfate;
scopolamine
hydrobromide.
86658............................................. Meprobamate;
tridihexethyl
chloride.
86665............................................. Phenobarbital;
atropine sulfate;
hyoscyamine
sulfate;
scopolamine
hydrobromide.
86667............................................. Chlordiazepoxide
hydrochloride;
clidinium bromide.
86668............................................. Phenobarbital;
belladonna alkaloid
malates, l-.
86669............................................. Dicyclomine
hydrochloride.
86670............................................. Atropine sulfate;
hyoscyamine
sulfate;
phenobarbital;
scopolamine
hydrobromide.
86671............................................. Phenobarbital;
hyoscyamine
sulfate.
86674............................................. Meprobamate;
tridihexethyl
chloride.
86675............................................. Butabarbital sodium;
simethicone;
atropine sulfate;
hyoscyamine
sulfate;
scopoamine.
86685............................................. Chlordiazepoxide
hydrochloride;
clidinium bromide.
86687............................................. Phenobarbital;
belladonna extract.
86692............................................. Amobarbital;
belladonna.
86694............................................. Oxyphencyclimine
hydrochloride;
phenobarbital.
86696............................................. Phenobarbital;
hyoscyamine
sulfate; atropine
sulfate;
scopolamine
hydrobromide.
86701............................................. Atropine sulfate;
phenobarbital.
86703............................................. Phenobarbital;
hyoscyamine
sulfate; atropine
sulfate;
scopolamine
hydrobromide.
86704............................................. Phenobarbital;
hyoscyamine
sulfate; atropine
sulfate;
scopolamine
hydrobromide.
86706............................................. Meprobamate;
tridihexethyl
chloride.
86708............................................. Cyproheptadine
hydrochloride.
86709............................................. Meprobamate;
tridihexethyl
chloride.
86721............................................. Procainamide
hydrochloride.
86770............................................. Nitroglycerin.
86773............................................. Triamcinolone
diacetate.
86774............................................. Erythrityl
tetranitrate.
86775............................................. Isosorbide
dinitrate.
86776............................................. Pentaerythritol
tetranitrate.
86777............................................. Nitroglycerin.
86779............................................. Nitroglycerin.
86782............................................. Nitroglycerin.
86783............................................. Isosorbide
dinitrate.
86784............................................. Pentaerythritol
tetranitrate.
86785............................................. Pentaerythritol
tetranitrate.
86786............................................. Isosorbide
dinitrate.
[[Page 35698]]
86789............................................. Estradiol valerate.
86794............................................. Dipyridamole.
86799............................................. Atropine sulfate;
phenobarbital.
86838............................................. Pentaerythritol
tetranitrate.
86839............................................. Isosorbide
dinitrate.
86868............................................. Chlorpromazine
hydrochloride.
86882............................................. Hydrocortisone.
86897............................................. Phenobarbital;
hyoscyamine
hydrobromide;
atropine sulfate;
scopolamine
hydrobromide.
86921............................................. Chlordiazepoxide
hydrochloride;
clidinum bromide.
86970............................................. Aminophylline.
86976............................................. Doxylamine
succinate;
pyridoxine
hydrochloride.
86991............................................. Probenecid.
86999............................................. Butalbital; aspirin;
phenacetin;
caffeine.
87000............................................. Hydralazine
hydrochloride.
87041............................................. Phendimetrazine
tartrate.
87064............................................. Piperazine citrate.
87069............................................. Sulfisoxazole
acetyl.
87096............................................. Phentermine
hydrochloride.
87097............................................. Phentermine
hydrochloride.
87098............................................. Phentermine
hydrochloride.
87099............................................. Phentermine
hydrochloride.
87106............................................. Ergotamine tartrate;
caffeine.
87112............................................. Spironolactone.
87116............................................. Reserpine;
chlorothiazide.
87123............................................. Benzthiazide.
87124............................................. Benzthiazide.
87125............................................. Diphenhydramine
hydrochloride.
87134............................................. Promethazine
hydrochloride.
87166............................................. Phentolamine
hydrochloride.
87172............................................. Theophylline.
87198............................................. Belladonna alkaloid
malates, l-;
phenobarbital.
87379............................................. Quinidine gluconate.
87443............................................. Homatropine
methylbromide;
phenobarbital.
------------------------------------------------------------------------
Dated: June 8, 2012.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2012-14476 Filed 6-13-12; 8:45 am]
BILLING CODE 4160-01-P